| Molecular recognition of muramyl dipeptide occurs in the leucine-rich repeat domain of Nod2 ML Lauro, EA D’Ambrosio, BJ Bahnson, CL Grimes ACS infectious diseases 3 (4), 264-270, 2017 | 55 | 2017 |
| The effect of NOD2 on the microbiota in Crohn's disease ML Lauro, JM Burch, CL Grimes Current opinion in biotechnology 40, 97-102, 2016 | 41 | 2016 |
| Differential peptidoglycan recognition assay using varied surface presentations EA D’Ambrosio, KL Bersch, ML Lauro, CL Grimes Journal of the American Chemical Society 142 (25), 10926-10930, 2020 | 22 | 2020 |
| Raman hyperspectral imaging with multivariate analysis for investigating enzyme immobilization JP Smith, M Liu, ML Lauro, M Balasubramanian, JH Forstater, ST Grosser, ... Analyst 145 (23), 7571-7581, 2020 | 20 | 2020 |
| Quantitation and speciation of residual protein within active pharmaceutical ingredients using image analysis with SDS-PAGE JP Smith, NM Ralbovsky, ML Lauro, E Hoyt, ED Guetschow, F Wang, ... Journal of Pharmaceutical and Biomedical Analysis 207, 114393, 2022 | 9 | 2022 |
| In situ real time monitoring of emulsification and homogenization processes for vaccine adjuvants NM Ralbovsky, RJ Soukup, JP Lomont, ML Lauro, A Gulasarian, ... Analyst 147 (3), 378-386, 2022 | 8 | 2022 |
| Crohn’s disease variants of Nod2 are stabilized by the critical contact region of Hsp70 AK Schaefer, HC Wastyk, V Mohanan, CW Hou, ML Lauro, JE Melnyk, ... Biochemistry 56 (34), 4445-4448, 2017 | 7 | 2017 |
| Probing the inflammatory response behind diabetes and obesity via the biochemical characterization of NOD1, an innate immune receptor T Rivas, M Lauro, C Grimes, B Bahnson The FASEB Journal 29, 559.40, 2015 | 6 | 2015 |
| Overcoming biopharmaceutical interferents for quantitation of host cell DNA using an automated, high-throughput methodology ML Lauro, AM Bowman, JP Smith, SN Gaye, J Acevedo-Skrip, ... The AAPS Journal 25 (1), 10, 2022 | 4 | 2022 |
| Conformational sampling and kinetics changes across a non-Arrhenius break point in the enzyme thermolysin M Dong, ML Lauro, TJ Koblish, BJ Bahnson Structural Dynamics 7 (1), 2020 | 3 | 2020 |
| Redefining the Defensive Line: critical components of the innate immune system CW Hou, ML Lauro, C Leimkuhler Grimes ACS infectious diseases 2 (11), 746-748, 2016 | 3 | 2016 |
| rsc. li/analyst NM Ralbovsky, RJ Soukup, JP Lomont, ML Lauro, A Gulasarian, ... Analyst 147, 371-377, 2022 | | 2022 |
| Narrowing down the minimal recognition motif for ligand sensing in the leucine-rich repeat domain of Nod2 M Lauro, E D'Ambrosio, B Bahnson, C Grimes ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | | 2017 |
| Molecular recognition of muramyl dipeptide by Nod2 and its implications in Crohn's disease and innate immunity ML Lauro University of Delaware, 2017 | | 2017 |
| Probing the molecular recognition of bacterial cell wall fragments by the C. albicans adenylyl cyclase, CYR1p J Burch, A Schaefer, J Melnyk, M Lauro, J Glowala, D Wykoff, C Grimes ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016 | | 2016 |
| Nod2 directly binds muramyl dipeptide through its leucine rich repeat domains in vitro M Lauro, B Bahnson, C Grimes ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016 | | 2016 |
| Biochemical Characterization of the Interaction between Innate Immune Receptor Nod2 and its Chaperones HC Wastyk, V Mohanan, A Schaefer, CW Hou, M Lauro, CL Grimes The FASEB Journal 30, 811.2-811.2, 2016 | | 2016 |
| Identification of critical binding interactions in Nod2, an innate immune receptor M Lauro, K DeMeester, CW Hou, B Bahnson, C Grimes ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016 | | 2016 |
| Molecular Characterization and Structural Determination of Nod2, an Innate Immune Receptor M Lauro, C Grimes, B Bahnson The FASEB Journal 29, 890.7, 2015 | | 2015 |
